 
        Partial Fasciectomy by Bruner Approach Versus Zetaplasty for Dupuytren Disease
 
                                                    Partial Fasciectomy by Bruner Approach Versus Zetaplasty for Dupuytren Disease
Dupuytren Disease Surgical Treatment: A Randomized Clinical Trial Comparing Partial Fasciectomy by Bruner Approach Versus Zetaplasty.
Hand (N Y) . 2024 Nov;19(8):1300-1307.Synopsis
Sixty-two adult patients with Dupuytren disease were randomized to receive partial fasciectomy using either the Bruner incision (n=23) or the zetaplasty incision (n=25). The primary outcome of interest was functional improvement measured by the DASH score. Secondary outcomes included correction of metacarpophalangeal (MP) and proximal interphalangeal (PIP) joint extension, pain levels using the vi...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.